<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58-pharmaceuticals-13-00455">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Braun</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Harris</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Katris</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Cain</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dhillon</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Koczwara</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Olver</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Robotin</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients</article-title>
  <source>Asia Pac. J. Clin. Oncol.</source>
  <year>2014</year>
  <volume>10</volume>
  <fpage>289</fpage>
  <lpage>296</lpage>
  <pub-id pub-id-type="doi">10.1111/ajco.12227</pub-id>
  <pub-id pub-id-type="pmid">25244342</pub-id>
 </element-citation>
</ref>
